Histaminergic fibers are present in the molecular and granular layers of the cerebellum and have high density in the vermis and flocculus. Evidence indicates that the cerebellar vermis is involved in memory consolidation. Recently, we demonstrated that when histamine is microinjected into the cerebellar vermis it results in impaired emotional memory consolidation in mice that are submitted to the elevated plus maze (EPM). This study investigated whether histamine impairment was mediated by the H 1 or H 2 receptors. The cerebellar vermis of male mice (Swiss Albino) were implanted using a guide cannula. Three days after recovery, behavioral tests were performed in the EPM on two consecutive days (Trial 1 and Trial 2). Immediately after exposure to the EPM (Trial 1), animals received a microinjection of histaminergic drugs. In Experiment 1, saline (SAL) or histamine (HA, 4.07 nmol/0.1 l) was microinjected 5 min after pretreatment with the H 1 antagonist chlorpheniramine (CPA, 0.16 nmol/0.1 l) or SAL. In Experiment 2, SAL or HA was microinjected into the mice 5 min after pretreatment with the H 2 antagonist ranitidine (RA, 2.85 nmol/0.1 l) or SAL. Twenty-four hours later, the mice were re-exposed to the EPM (Trial 2) under the same experimental conditions but did not receive an injection. On both days, the test sessions were recorded to enable analysis of the behavioral measures. The decrease in open arm exploration (% entries and % time spent in the open arms) in Trial 2 relative to Trial 1 was used as a measure of learning and memory. The data were analyzed using the two-way analysis of variance (ANOVA) and Duncan's tests. In Experiment 1, the Duncan's test indicated that the mice entered the open arms less often (%OAE) and spent less time in the open arms (%OAT) in Trial 2 after being microinjected with SAL + SAL, SAL + CPA and CPA + HA. However, the animals that received SAL + HA did not enter the open arms less frequently or spend less time in them, which was significantly different from the CPA + HA group. The results of Experiment 2 demonstrated that the %OAE and %OAT in Trial 2 were different from Trial 1 for the groups that were microinjected with SAL + SAL and SAL + RA. The animals that were microinjected with RA + HA or with SAL + HA did not show a reduction in %OAE. These results demonstrate that the animals treated with HA did not avoid the open arms less on retesting and indicated that CPA did not alter the behavior parameters but did revert the histamine-induced impairment of memory consolidation. Furthermore, the H 2 antagonist RA, at the dose used in this study, did not affect memory consolidation and failed to revert histamine-induced impairment.
Introduction
Histamine is an important neurotransmitter-neuromodulator in the central nervous system (CNS). Histaminergic neurons are located exclusively in the tuberomammillary nucleus. From there, they project to all regions of the brain, including the cerebellum, which contains high density of histaminergic terminations in the vermis and flocculus (Panula et al., 1989; Wada et al., 1991) . Histamine-immunoreactive fibers are located in the molecular and granular layers of the cerebellum in several species, including humans. These fibers run parallel to the Purkinje cell layer after 0361-9230 © 2012 Elsevier Inc. http://dx.doi.org/10.1016/j.brainresbull.2012.09.003
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traversing perpendicular to it (Hass and Panula, 2003; Panula et al., 1993) .
Autoradiographic mapping and in situ hybridization experiments demonstrated the presence of H 1 and H 2 receptors in the rat cerebellar cortex and deep in the cerebellar nuclei (Arrang et al., 1995; Pollard et al., 1993) . These studies suggest that histamine may play an important role in modulating the excitability of cerebellar neurons. The Purkinje cells of the cerebellar cortex and the neurons in the nucleus interpositus all exhibit H 2 receptormediated excitatory responses when exposed to a histamine bath perfusion (Shen et al., 2002) . Granule cells are excited through the activation of the H 1 and H 2 receptors (Li et al., 1999; Tian et al., 2000) .
Recently, evidence has been presented indicating that the cerebellum, in addition to being a motor coordination center, is also involved in modulation of emotional behavior (Schmahmann et al., 2007; Strata et al., 2011; Tavano and Borgatti, 2010) . Additionally, the vermal part of the cerebellum has been implicated in emotional or fear-related behaviors (Sacchetti et al., 2009; Storozheva, 2009 ). According to Sacchetti et al. (2005) , the fact that there is a functional interconnection between the cerebellar vermis and the hypothalamus, amygdala, and hippocampus suggests that the cerebellum may play a role in the integrated network that regulates emotional behavior.
Studies have related the cerebellar vermis to emotional memory consolidation (Sacchetti et al., 2002; Storozheva, 2009) . In one study, inactivation of the vermis caused amnesic effects after a fearconditioning task (Sacchetti et al., 2002) . Other findings indicate that after training the cerebellar vermis is selectively involved in long-term memory formation for certain types of defense behaviors (Storozheva, 2009) . Thus, the participation of the vermis in emotional memory may be independent of its role in sensory or motor processes, and the vermis may represent an interface between sensory stimuli, the emotional state, and motor responses (Sacchetti et al., 2005 (Sacchetti et al., , 2009 .
The neural histaminergic system is involved in several behavioral and neurobiological functions, such as arousal, food intake, motor activity, and nociception (Brown et al., 2001; Hass and Panula, 2003) . However, the part histaminergic circuits play in mnemonic effects is complex. Histamine seems to have different effects in distinct brain regions and may have modulatory effects that differ according to the memory type. The exact role of this neurotransmitter in learning processes and memory consolidation, the action of the receptor subtypes and how they affect key circuits related to a specific memory system are not well understood (Köhler et al., 2011) .
Histaminergic modulation of learning and memory was studied using lesions and pharmacological interventions in the tuberomammillary nucleus and other decisive brain regions. However, the role of the cerebellar histaminergic system on memory has not been investigated. In our first study, microinjection of histamine into the cerebellar vermis demonstrated that the cerebellar histaminergic system is involved in the process of consolidation of emotional memory. These results indicated that there was a dose-dependent inhibition of memory consolidation when histamine was injected into the cerebellar vermis in mice re-exposed to the elevated plus maze (Gianlorenç o et al., 2011a) . Therefore, in the present study we investigated whether histamine impairment was mediated by the H 1 and/or H 2 receptors.
Materials and methods

Subjects
Male Swiss mice (Federal University of São Carlos, UFSCar, SP, Brazil) weighing 25-35 g at the beginning of the experiments were housed in polypropylene cages (31 cm × 20 cm × 13 cm) in groups of five and were maintained under a 12 h light cycle (lights on at 7:00 a.m.) in a controlled environment at a temperature of 23 ± 1 • C and a humidity level of 50 ± 5%. Food and drinking water were provided ad libitum, except during the brief test periods. All mice were experimentally naive, and the experimental sessions were conducted during the light period of the cycle (9:00-13:00 h).
Drugs
Histamine dihydrochloride, the H1 receptor antagonist, chlorpheniramine maleate salt and the H2 receptor antagonist ranitidine hydrochloride (Sigma Chemical Co., USA) were prepared in a vehicle of physiological saline. Saline solution was used as an experimental control. The doses were based on previous research (Gianlorenç o et al., 2011a ) and on pilot work in our laboratory. The substances were coded, and the experimenter was blinded to the codes when the tests and behavioral analysis were performed.
EPM apparatus
The EPM used was similar to the one originally described by Lister (1987) . The EPM consisted of two open arms (30 cm × 5 cm × 0.25 cm) and two enclosed arms (30 cm × 5 cm × 15 cm) that were connected to a common central platform (5 cm × 5 cm). The apparatus was made of crystal acrylic and was raised 38.5 cm above floor level.
Stereotaxic surgery and drug infusion
Mice were intraperitoneally anesthetized using ketamine hydrochloride (100 mg/kg) and xylazine (10 mg/kg) solution in association with local anesthesia (3% lidocaine with norepinephrine 1:50,000) and were placed in a Stoelting stereotaxic instrument. A single, 7 mm, stainless steel guide cannula (25 gauge) was implanted in the cerebellar vermis according to the following coordinates from the mouse brain atlas (Franklin and Paxinos, 2001 ): 6.5 mm posterior to the bregma, 0 mm lateral to the midline, and 2.0 mm ventral to the skull surface. The guide cannula was fixed to the skull using dental acrylic and jeweler's screws. A dummy cannula (33 gauge stainless steel wire) was inserted into the guide cannula at the time of surgery to reduce the incidence of occlusion. Postoperative analgesia was provided for 3 days by adding acetaminophen (200 mg/ml) to the drinking water in a ratio of 0.2 ml acetaminophen to 250 ml water (i.e., the final concentration was 0.16 mg/ml).
Saline and drug solutions were infused into the cerebellar vermis using a microinjection unit (33 gauge cannula; Insight Equipamentos Científicos Ltda, Brazil), which extended 2.0 mm beyond the tip of the guide cannula. The microinjection unit was attached to a 5-l Hamilton microsyringe via polyethylene tubing (PE-10), and the administration was controlled by an infusion pump (Insight Equipamentos Científicos Ltda, Brazil) that was programmed to deliver a volume of 0.1 l over a period of 60 s. The microinjection procedure consisted of gently restraining the animal, inserting the injection unit, infusing the solution, and keeping the injection needle in situ for a further 60 s to avoid reflux. Confirmation of successful infusion was obtained by monitoring the movement of a small air bubble inside the PE-10 tubing.
General conditions and data collection
Three days after surgery, the animals were transported to the experimental room and left undisturbed for at least 1 h before testing to facilitate adaptation. The test was performed on two consecutive days, and the trials in the EPM were denoted Trial 1 and Trial 2. Mice were individually placed on the central platform of the maze facing the open arm and were able to explore the maze for 5 min.
In Trial 1, immediately after exposure to the EPM, the animals received a microinjection of the drugs. In Experiment 1, saline (SAL) or 4.07 nmol histamine (HA) was microinjected 5 min after pretreatment with 0.16 nmol chlorpheniramine (CPA). In Experiment 2, SAL or 4.07 nmol HA was microinjected 5 min after pretreatment with 2.85 nmol ranitidine (RA). Twenty-four hours later (Trial 2), the mice were re-exposed to the EPM under the same experimental conditions as in Trial 1 with the exception that they did not receive an injection. Between subjects, the maze was thoroughly cleaned with 5% ethanol and a dry cloth. All tests were conducted under moderate illumination (77 lx) as measured on the central platform of the EPM and in an environment isolated from the rest of the room by a black protective curtain.
All sessions were video recorded with a digital camera that was linked to a computer in an adjacent room. Images were analyzed by a highly trained observer using X-PLO-RAT, which is an ethological analysis software package developed at the Laboratory of Exploratory Behavior USP/Ribeirao Preto (Garcia et al., 2005) . Behavioral parameters were defined in a way that was consistent with previous studies (Lister, 1987; Rodgers and Johnson, 1995) in the enclosed arms (%EAT = (enclosed time/300) × 100). The number of stretchedattend postures (SAP; exploratory posture in which the body stretches forward and then retracts to its original position without any forward locomotion), immobility time (stillness but some movement of the chest), and the frequency of head dipping (HD; exploratory movement of head/shoulders over the sides of the maze) were also scored. Total SAP was considered a primary index of risk assessment, and head dipping was considered an index of exploratory behavior (Rodgers et al., 1997 ).
Histology
At the end of testing, all animals received a 0.1 l infusion of 1% methylene blue according to the microinjection procedure described above. The animals received an anesthetic overdose, their brains were removed and the injection sites were verified histologically according to the atlas of Franklin and Paxinos (2001) . Data from animals with injection sites outside the cerebellar vermis were excluded from the study. The final sample size of each cohort ranged between 9 and 13. Histology confirmed that a total of 87 mice had accurate cannula placement mainly in the anterior and central vermis in the lobules V and VI (Fig. 1) .
Statistical analysis
All results were initially analyzed using the Levene's test for homogeneity of variance. The data were analyzed using the two-way repeated measures ANOVA (factor 1: treatment; factor 2: trial). When differences were indicated by significant F values, they were further analyzed using Duncan's multiple range tests. A p value of less than 0.05 was considered significant.
Ethics
The experiments performed as part of in this study were approved by the Animal Ethics Commission of the Federal University of Sao Carlos (CEEA 049/09) and are in compliance with the norms of the Brazilian Neuroscience and Behavior Society (SBNeC), which are based on the US National Institutes of Health Guide for Care and use of Laboratory Animals.
Results
3.1. Experiment 1: pretreatment with the H 1 receptor antagonist CPA prevents the HA-induced impairment of memory consolidation As summarized in Fig. 2A and B and Table 1, the two-way ANOVA revealed no significant differences among groups in Trial 1 for all the measures analyzed. However, there were differences in the %OAE between trials ( CPA + SAL  CPA + HA  SAL + HA   T1  T2  T1  T2  T1  T2  T1  T2 OAE 6.5 ± 0.7 2,7 ± 0.6 * 7.4 ± 1.5 3.9 ± 0.8 .4 ± 1.2 4.2 ± 0.8 7.2 ± 1.1 6.7 ± 1.0 HD 6.9 ± 0.9 1.6 ± 0.6 that received SAL + HA (p = 0.84) and the %OAE was significantly different from the CPA + HA group (p = 0.007) ( Fig. 2A ). These results demonstrate that the animals treated with HA did not avoid the open arms more during retesting, indicating that the CPA did not alter behavioral parameters but prevented the histamineinduced impairment of memory consolidation. Table 1 shows the results for all other behaviors. The ANOVA showed no significant differences in EAE among groups (F 1 , 38 = 1.54, p = 0.22), which is an EPM index of general exploratory activity. The ANOVA revealed significant differences between trials in OAT (F 1,38 = 18.53, p = 0.0001) and OAE (F 1,38 = 25.24, p = 0.00001). Post hoc comparisons indicated that these differences were present for the groups that were microinjected with SAL + SAL, CPA + SAL, and CPA + HA. Additionally, there were significant differences between the groups SAL + HA and SAL + SAL (OAE, p = 0.03) and between SAL + HA and CPA + HA (OAE, p = 0.004; OAT, p = 0.02). Furthermore, there were differences between sessions for EAT (F 1,38 = 63.42, p < 0.00001), %EAT (F 1,38 = 63.42, p < 0.00001), CT (F 1,38 = 14.39, p = 0.0005), total SAP (F 1,38 = 7.41, p = 0.01), and frequency of head dipping (F 1,38 = 36.27, p < 0.00001). The ANOVA did not detect any significant differences in immobility time (F 1,38 = 0.84, p = 0.37) between trials.
SAL + SAL
Experiment 2: the effects of pretreatment with the H 2 receptor antagonist RA on HA-impairment of memory consolidation
The two-way ANOVA test revealed that there were no significant differences between the groups in Trial 1 for any of the measures analyzed (Table 2) . However, there were differences in the %OAE (F 1 , 45 = 15.31, p = 0.0003) between trials. The post hoc analysis indicated that differences in the %OAE existed in groups that were microinjected with SAL + SAL (p = 0.02) and RA + SAL (p = 0.05). The animals that received pretreatment with RA (RA + HA) (p = 0.23) and animals microinjected with SAL + HA (p = 0.21) did not have a reduced %OAE (Fig. 3A) . Fig. 3B shows the %OAT for the first and second sessions. The ANOVA revealed that there were differences in the %OAT between sessions (F 1,45 = 20.53, p = 0.00005). Duncan's test indicated that the animals that were microinjected with SAL + SAL (p = 0.002), RA + SAL (p = 0.04), and RA + HA (p = 0.03) exhibited a decreased %OAT in Trial 2 relative to Trial 1. These results indicated that the H 2 antagonist RA, at the dose used in this study, did not have an effect on memory consolidation and that it failed to prevent entirely histamine impairment.
Table 2
Effects of the combined injection of the H2 antagonist RA (2.85 nmol) and histamine (4.07 nmol) on the behavior of mice in Trials 1 and 2 in the EPM. T1  T2  T1  T2  T1  T2  T1  T2 OAE 6.1 ± 0.9 3.4 ± 1.1 7.2 ± 1.4 4.7 ± 1.4 8.5 ± 1.0 5.7 ± 0.9 7.1 ± 1. 118.0 ± 20.5 75.9 ± 16.9 90.5 ± 12.5 94.4 ± 15.5 104.6 ± 9.8 81.4 ± 13.4 SAP 7.5 ± 1.0 4.2 ± 0.9 7.5 ± 1.0 6.3 ± 1.8 5.4 ± 1.1 6.6 ± 1.1 7.9 ± 1.1 7.3 ± 1.0 HD 10.9 ± 3.2 1.4 ± 0.6 
Discussion
The primary findings of the present study are that pre-treatment with the H 1 antagonist CPA was able to completely abolish the effect on intra-cerebellar histamine impaired emotional memory consolidation in mice submitted to the EPM, whereas combined microinfusion with the H 2 antagonist RA failed to reverse the histamine effect.
In the EPM, memory acquired during the first exposure is related to an anxious emotional state. The behaviors expressed during the test are due to a conflict between motivation to explore the maze and the natural tendency to avoid open spaces (Bertoglio and Carobrez, 2000; Lister, 1987) . According to File et al. (1990) , after the initial exploration of the apparatus, rodents acquire, consolidate and retrieve some memory related to exploration of potentially dangerous areas of the maze. Several studies show that EPM-experienced animals exhibit a significant decrease in %OAE and %OAT during retesting (Bertoglio and Carobrez, 2000; Galvis-Alonso et al., 2010) . In a recent study, Gazarini et al. (2011) demonstrated that pretest and posttest dorsal hippocampus anisomycin infusion do not interfere with the further avoidance to open arms exhibited by rats in the EPM retest, and according to the authors, the test/retest protocol in the EPM is an effective tool that can be used to investigate memory.
This study confirms our early results, which demonstrated that animals microinjected with 4.07 nmol histamine did not explore the open-arms less during retesting in the EPM, indicating that histamine has an inhibitory effect on memory (Gianlorenç o et al., 2011a) . However, the combined injection with saline (SAL + HA) induced a less pronounced effect on memory consolidation, since there was an absence of a significant difference between the control group (SAL + SAL) and the group treated with HA.
Histaminergic circuits play a complex role in the mnemonic system. Histamine has different effects in distinct brain regions and may produce modulatory effects that differ according to memory type (Benetti et al., 2012; Da Silva et al., 2006; Köhler et al., 2011) . Our results show that the histaminergic system may have an inhibitory effect in the memory consolidation process with an anxiety component. The histaminergic projections to the cerebellar vermis, amygdala and hippocampus can be involved in the modulation of this role. It has been previously proposed that the amygdala and cerebellum are functionally interconnected during aversive learning (Turner et al., 2007) . According to Sacchetti et al. (2009) , the vermis and amygdala may interact, and the vermal electrical stimulation modulates amygdala activity. These effects are mediated by both direct and indirect anatomical connections between the cerebellum and the limbic areas.
Evidence demonstrates the existence of the histaminergic receptors H 1 , H 2 and H 3 in the cerebellum of rodents (Arrang et al., 1995; Pollard et al., 1993) . Generally, H 1 and H 2 receptors excite or potentiate excitatory impulses (Gianlorenç o et al., 2011b; Pollard et al., 1993) , while H 3 activation mediates autoinhibition of TMN neurons (Arrang et al., 1985; Hass and Panula, 2003) . According to a recent review, the H 1 receptor is the predominant histaminergic receptor in the cerebellum (Köhler et al., 2011) .
In Experiment 1, the microinfusion of CPA did not alter behavioral parameters by itself, but when CPA was administrated prior to HA it reduced the open arm exploration and showed a significant difference from the group that was microinjected with HA only. Therefore, pre-treatment with CPA abolished the inhibitory effect of HA on memory consolidation, which indicates that this receptor is possibly involved in histamine induced memory impairment.
One possible mechanism to be explored is whether the administration of the H 1 antagonist CPA enhanced histamine levels in the synaptic cleft and increased the synaptic availability of histamine and its binding to H 3 receptors. Activation of H 3 receptors would be responsible for inhibition of the synthesis and release of endogenous histamine, which reverses the memory impairment. However, since CPA is not highly selective for H 1 receptors, we cannot exclude the possibility of interactions with other neurotransmitters systems, such as the serotoninergic and cholinergic systems (Benetti et al., 2012; Hasenöhrl et al., 1999) .
Evidence regarding the role of the histaminergic system in the learning and memory process is controversial. In addition, the function of the histaminergic receptors and how they affect the memory system is still unclear (Köhler et al., 2011) . Some studies that investigated the role of the H 1 receptor in memory found that the intraventricular infusion of CPA improved water maze performance in aged rats (Hasenöhrl et al., 1999) and improved the one-trial step through passive avoidance retention (Zarrindast et al., 2002) . However, blockade of the H 1 receptor impaired working and reference memory (Chen et al., 2001) . Studies with H 1 knockout mice demonstrated that their inhibitory avoidance performance was unaffected (Yanai et al., 1998) and that their object recognition performance was impaired (Daí et al., 2007) . In the EPM, systemic CPA did not have an effect on emotional memory (Gianlorenç o et al., 2011b) .
Studies have examined the effects of H 2 antagonists on cognitive performance. In the study by Flood et al. (1998) , intra-septal infusion of dimaprit (H 2 agonist) facilitated long-term retention of an avoidance learning task. The results from Alvarez and Banzan (2008) demonstrated that pretreatment with RA blocked the inhibitory effect of histamine on memory consolidation. Recently, Benetti et al. (2012) suggested that activation of postsynaptic H 2 receptors within the nucleus basalis magnocellularis by endogenous histamine is responsible for the potentiated expression of fear responses. In Experiment 2, the H 2 antagonist RA did not have an effect on open arm exploration by itself and when RA was administered before histamine, RA was not able to reverse the inhibitory effect of histamine on memory. This suggests that H 2 receptors in the cerebellar vermis likely do not play a role in the inhibitory effect of histamine on the EPM.
Emotional memory plays an important role in controlling behavior and it is critical for the survival of individuals and of species. An emotional memory deficit could lead to the exposure of an individual to numerous dangerous situations while the persistence of an aversive memory is a considerable factor associated with the development of anxiety and fear disorders, including phobias and posttraumatic stress disorder (PTSD). Therefore, in view of our results, there is a potential importance of these histaminemodulated effects leading to emotional memory erasure. Further research is warranted to better understand the importance of the histaminergic system to trauma-related disorders.
Conclusion
In conclusion, the results of the present study demonstrate that H 1 receptors in the cerebellar vermis mediate memory consolidation impairment induced by histamine in mice re-exposed to the EPM.
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